Conversely, IL-27R agonism through hydrodynamic tail vein injection of IL-27-encoding plasmid resulted in complete tumor control without relevant toxicity, a common side effect associated with cytokine-based therapies (Fig. 1b). The gene discussed is IL27RA; the disease is neoplasm.